Latest current cash for SRTAW: $16M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Strata Critical Medical (SRTAW) currently reports a current cash of $16M as of June 2026. That compares with $59M in the prior-year period — down 72.2% year over year. Use the charts on this page to explore Strata Critical Medical's current cash history and peer comparisons.
Strata Critical Medical's current cash decreased from $59M to $16M — a 72.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Strata Critical Medical reported $16M in current cash as of June 2026. That compares with $59M in the prior-year period — down 72.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Strata Critical Medical, and consider following SRTAW for alerts when major investors trade the stock.
Strata Critical Medical is classified in the Industrials sector. On current cash, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing SRTAW with unrelated industries.